National Heart, Lung, and Blood Institute, Notice of Closed Meetings

Download PDF
Federal RegisterJun 22, 2000
65 Fed. Reg. 38837 (Jun. 22, 2000)

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute, Special Emphasis Panel, Clinical Research Curriculum Awards (K30s)

Date: July 11-12, 2000.

Time: 7:00 PM to 5:00 PM.

Agenda: To review and evaluate grant applications.

Place: Chevy Chase Holiday Inn, 5520 Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: Diane M. Reid, MD, Scientific Review Administrator, NIH, NHLBI, DEA, Two Rockledge Center, 6701 Rockledge Drive, Room 7182, Bethesda, MD 20892-7924 (301) 435-0277.

Name of Committee: National Heart, Lung, and Blood Institute, Special Emphasis Panel, In Vitro Inactivation of Viruses in Blood Components.

Date: July 20, 2000.

Time: 8:00 AM to 4:00 PM.

Agenda: To review and evaluate grant applications.

Place: Holiday Inn-Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Eric H. Brown, PhD Scientific Review Administrator, NIH/NHLB/DEA Review Branch, Rockledge Building II, Suite 7204, 6701 Rockledge Drive, Bethesda, MD 20892-7924, 301/435-0299, browne@gwgate.nhlbi.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: June 15, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-15757 Filed 6-21-00; 8:45 am]

BILLING CODE 4140-01-M